Skip to main content

CSL CEO: Let's Shine a Light on Rare Diseases

Rare Disease Day on February 29 offers a chance to show solidarity with the estimated 300 million people living with rare diseases, CSL CEO Paul McKenzie said in a video message.


CSL will take part in Rare Disease Day later this month, an event that includes the Global Chain of Lights to raise awareness about the approximately 7,000 known rare diseases and their impact on millions of patients, family members and caregivers, CEO Paul McKenzie said.

“Rare Disease Day acknowledges the patients we work for – and with – as we strive to develop innovative treatments,” he said in a video message.

Last year, the global biotech helped light up landmarks in Philadelphia, Pennsylvania, and Marburg, Germany. New illumination projects are planned for Rare Disease Day on the last day of the month, February 29. Learn more about Rare Disease Day and how to get involved.

CSL includes business units CSL Behring, which makes medicines for people who have rare and serious diseases; CSL Seqirus, which develops and manufactures vaccines; and CSL Vifor, a leader in iron deficiency and nephrology (kidney care).